Bionutrics, Inc. Awarded New U.S. Patent for Tocotrienol Compositions and Processing Technologies.Business Editors/Biotechnology Writers PHOENIX--(BUSINESS WIRE)--April 3, 2001 Bionutrics, Inc., (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :BNRX) announced today that its wholly owned R&D subsidiary, LipoGenics, Inc., has been awarded a US patent that further enhances/extends Bionutrics processing methods and novel pipeline of proprietary products. LipoGenics, Inc., has been issued US Patent No. 6,204,290 for new tocotrienol tocotrienol one of the eight structurally related compounds which are grouped together as vitamin E; tocotrienol indicates a compound with an unsaturated side chain. processing methods and compositions produced by these methods. The patent involves the extraction extraction /ex·trac·tion/ (eks-trak´shun) 1. the process or act of pulling or drawing out. 2. the preparation of an extract. of a tocotrienol rich fraction (TRF TRF thyrotropin releasing factor. ) from plants and other materials (such as rice bran) and also protects the TRF and related products extracted using the claimed methods. The Phoenix, AZ-based Company concentrates on the discovery and development of novel biologically active compounds derived from natural sources. The extracted product has potential applications in ethical drugs and can also be used as a functional nutritional ingredient. Ronald H. Lane, Chairman, President and Chief Executive Officer of Bionutrics, Inc., commented, "This patent authenticates our core technology and extends value and protection to our manufacturing and marketing partners. Bionutrics has established the protection of intellectual properties as a corner stone of its business model. Only the ownership of technology maximizes the full commercial potential of that technology." Mr. Lane continues, "The Company's commitment to building a solid intellectual property foundation is not only for our novel products, but also for the methods we develop to produce these novel products. We intend to continue our aggressive pursuit of protection for tocotrienol and similar compounds, while further concentrating on other complementing opportunities available to the Company." Wendy Wendy is a female name which may be used as a short form for Gwendolyn, or in its own right. Its popularity is attributed to the character Wendy Darling from the children's play and novel Peter Pan, by J.M. Barrie. The character Wendy was inspired by a real girl. E. Rieder For the town in the district of Quedlinburg, see Rieder, Saxony-Anhalt. Rieder is a Thuringian (Germany) municipality in the district of Eichsfeld. , Esq., Vice President of Intellectual Property for LipoGenics, Inc., remarked, "LipoGenics is very pleased by the issuance of our latest US patent. This processing and product-by-process patent speaks to the importance the Company places on protecting its processing methods, as well as the composition and use of its developed products. The strategic focus of Bionutrics on the recovery of biologically active compounds from food processing Food processing is the set of methods and techniques used to transform raw ingredients into food for consumption by humans or animals. The food processing industry utilises these processes. by-product by·prod·uct or by-prod·uct n. 1. Something produced in the making of something else. 2. A secondary result; a side effect. by-product Noun 1. streams dictates the significance of developing and protecting the Company's novel processing methods." "This is the fourth US patent issued to LipoGenics in the past twelve months and is part of Bionutrics' growing estate of 31 patents worldwide. LipoGenics' US and foreign patents cover many different aspects of our tocotrienol technology platform, ranging from processing methods to novel chemical entities. The Company's intent is to create proprietary products with specific and sustainable benefits for our strategic partners and ultimately the consumer. We are proud of our patenting accomplishments and continue to work on the expansion of these assets and the protection of our critical intellectual property base," Ms. Rieder concluded. Bionutrics is a biopharmaceutical company founded to discover and develop novel biologically active compounds derived from natural sources. Natural, biologically active compounds have potential applications as functional nutrition ingredients as well as ethical drugs. Bionutrics is presently developing proprietary functional nutrition ingredients and pharmaceutical products and intends to market these products through strategic alliances. "Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. " statement under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995: This release contains forward looking statements that are subject to the risks and uncertainties, including, but not limited to, the impact of competitive products and pricing, product demand and market acceptance, new product development, future research, reliance on key strategic alliances, availability of raw materials, the regulatory reg·u·late tr.v. reg·u·lat·ed, reg·u·lat·ing, reg·u·lates 1. To control or direct according to rule, principle, or law. 2. environment and governmental approval processes, fluctuations in operating results and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission. |
|
||||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion